PADN (Pulmonary Artery Denervation)

· Pulnovo Medical (Wuxi) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PADN (Pulmonary Artery Denervation), covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Study for Evaluation of Safety and Efficacy of PADN to Treat Combined Post- and Pre- Capillary Pulmonary Hypertension Associated With Chronic Heart Failure（PADN-CpcPH-PILOT） [NA]

See pricing